6.7
Complementação de exame. Vide parecer.
06/06/2023
RPI 2735
Application data
Number
112020022190Type
Filing
Publication
PCT
CN2019085327 The INPI issued a technical office action on this application. If it is not answered in time, the application is abandoned (art. 36 of the Brazilian IP Act).
Latest action published by the INPI: 06/06/2023. We update with every new RPI gazette, published weekly.
Applicants
TIANJIN HEMAY PHARMACEUTICAL CO., LTD.
CN
Inventors
D. Z. (pessoa física)
CN
L. W. (pessoa física)
CN
Y. C. (pessoa física)
CN
IPC Classification
Priority claims
CN
201810407741.X · 05/02/2018
Abstract
FORMA DE CRISTAL DE DERIVADO DE TIOFENO.A invenção refere-se a uma forma de cristal I de um composto, isto é, (S)-N-[5-[1-(3-etóxi-4-metoxifenil)-2-(metilsulfonil)etil]-4,6-dioxo-5,6-di-hidro-4H-tiofeno[3,4-c]pirrol-1-il]acetamida.
Publications in the Brazilian Industrial Property Gazette (RPI).
Complementação de exame. Vide parecer.
06/06/2023
RPI 2735
#6.23
03/28/2023
RPI 2725
#15.35
12/14/2021
RPI 2658
#1.3
02/02/2021
RPI 2613
#1.1
11/10/2020
RPI 2601
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.